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Abstract
Although cell-to-cell HIV transmission was defined in early 90's, in the last five years, several groups
have underscored the relevance of this mode of HIV spread between productively infected and
uninfected CD4 T cells by defining the term virological synapse (VS). However, unraveling the
molecular mechanisms of this efficient mode of viral spread appears to be more controversial than
expected. Different authors have highlighted the role of a classical co-receptor-dependent HIV
transmission while others describe a co-receptor-independent mechanism as predominant in VS.
By analyzing different cellular models (primary cells and cell lines), we suggest that primary cells are
highly sensitive to the physical passage of viral particles across the synapses, a co-receptor-
independent phenomenon that we call "HIV transfer". Once viral particles are transferred, they can
infect target cells by a co-receptor-dependent mechanism that fits with the classical meaning of
"HIV transmission" and that is much more efficient in cell lines. Differences in the ability of primary
CD4 T cells and cell lines to support HIV transfer and transmission explain most of the reported
controversial data and should be taken into account when analyzing cell-to-cell HIV spread.
Moreover, the terms transfer and transmission may be useful to define the events occurring at the
VS. Thus, HIV particles would be transferred across synapses, while HIV infection would be
transmitted between cells. Chronologically, HIV transfer is an early event occurring immediately
after the VS formation, which precedes but does not inevitably lead to transmission, a late event
resulting in infection.
Commentary
Cell mediated HIV transmission is a highly efficient mech-
anism of HIV spread [1]. In vitro, mobile lymphocytes do
not support efficient HIV replication due to their inability
to form cellular conjugates [2], while in vivo, most of CD4
T cells are multiply infected, a fact hardly explained by
cell-free virus infection [3]. Since the early 90's, cell-to-cell
HIV transmission has been intermittently described in the
literature [4-6]. However, after the description of the VS
formed by HTLV-1 [7], this concept has been widely
explored in the study of HIV infection. Initial work
defined the structure of HIV-induced VS, in which the
viral envelope glycoprotein (gp120/gp41, Env) and its pri-
mary receptor CD4, expressed respectively on the surface
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of infected and uninfected cells, form the central ring
[1,8]. Moreover, confocal microscopy showed the crucial
role of the cytoskeleton and the recruitment of the viral
structural protein Gag and the co-receptor (CXCR4 or
CCR5) to the areas of contact between the T cells [8]. More
recently, several authors have reported the modulation of
the VS by adhesion molecules, although their functional
role does not appear to be essential for HIV spread
between T cells [9,10]. These results outline the VS as a sta-
ble conjugation of infected and uninfected cells involving
cell surface receptors. The VS allows for a polarized HIV-
release towards the synaptic space wherein viral particles
are highly concentrated and efficiently captured by target
cells. Besides this, different cellular functions have been
explored in the context of cell-to-cell HIV transmission,
such as nanotubes or filopodia that may complement the
VS, allowing HIV transfer between non-conjugated cells
[11,12]. Alternatively, the formation of nanotubes or filo-
podia into the VS may allow for the exchange of mem-
brane patches between conjugated cells, a phenomenon
known as trogocytosis [13], which may play a role in HIV
transmission [14].
It has been widely observed that the formation of the syn-
aptic structure is dependent on Env binding to CD4
[9,10,15]. However, the role of the co-receptor during the
early events of the VS is still under discussion [16]. A
reduction in the function of the VS after co-receptor block-
ade has been reported [8], suggesting that co-receptor
binding precedes Gag co-localization at the VS. However,
it has been reported that primary CD4 T cells capture HIV
particles by a co-receptor-independent endocytic mecha-
nism [10,15,17,18], and that co-receptor antagonists,
fusion inhibitors or neutralizing antibodies directed
against the gp41 subunit, do not reduce the amount of
HIV particles that cross the VS in several cell-to-cell HIV
transmission models [14,15,18]. Again, this is not an
unanimous opinion, since other authors do not describe
co-receptor-independent capture of HIV [8] or suggest
that it is marginal during cell-to-cell HIV transmission
[19].
We believe that part of this discrepancy may be explained
by the use of primary cells or cell lines as target cells which
behave differently in their ability to capture HIV particles
and to become productively infected after engaging the
VS. To better describe the mechanisms of cell-to-cell HIV
transmission in the different target cells, we suggest the
use of the term "transfer" when referring to the physical
passage of HIV particles from infected to uninfected cells,
and we suggest keeping the term "transmission" when this
transfer leads to infection of the target cells. Understand-
ing the chronological and causal relationships between
HIV transfer and transmission will be required to defini-
tively find out how HIV spreads in vivo.
HIV transfer versus HIV transmission
To date, cell-to-cell HIV transmission to primary CD4 T
cells [8,10,14,15,18] and cell lines [15,19] has yielded
somewhat discordant results. To understand these differ-
ences, we have analyzed two different co-culture models,
in which MOLT cells chronically infected with the X4 and
R5 isolatesNL4-3 and BaL, were used as effector cells and
co-cultured, on the one hand, with primary CD4 T cells or,
on the other hand, with the CD4+/CXCR4+ but CCR5-
MT-4 cell line. In both models, HIV materials associated
with target cells can be measured after intracellular labe-
ling of the Gag antigen (p24) (see additional file 1 for
details).
After 2 hours of co-culture, p24 staining can be observed
in both the MT-4 cell line and primary CD4 T cells co-cul-
tured with both HIV infected MOLT cells. Addition of the
fusion inhibitor C34 did not significantly alter the extent
of p24 staining of both target cells whereas the blocking
anti-CD4 antibody Leu3a abrogated the capture of p24
antigen. As the X4 and the R5 isolates induced similar HIV
transfer regardless of the low or absent CCR5 expression
in primary cells and MT-4 cells respectively, HIV appears
to be initially transferred to target cells in a co-receptor-
and fusion-independent manner [18,20] (additional file
2).
A more complex scenario appears at longer incubation
times (24 hours). MT-4 cells co-cultured with MOLT NL4-
3 infected cells become totally positive for intracellular
p24 antigen with a very high intensity that was vastly
reduced by the addition of the fusion inhibitor C34, the
blocking anti-CD4 antibody Leu3a (additional file 2) or
the Reverse Transcriptase inhibitor AZT (data not shown),
confirming the existence of a highly efficient process of
productive infection acknowledged as HIV transmission.
The remaining fusion-independent p24 staining in the
presence of C34 was comparable to that observed after 24
hours of co-culture between MT-4 and BaL-infected MOLT
cells and may be identified as the co-receptor-independ-
ent transfer of HIV materials (additional file 2). In con-
trast, primary CD4 T cells behave in a different manner in
long duration co-cultures. Primary CD4 T cells which inti-
mately contact NL4-3 infected MOLT cells, die by Env-
mediated hemifusion and fusion mechanisms [21,22].
The addition of C34 protects CD4 T cells from dying and
at the same time notably increases the amount of p24
transferred to primary CD4 T cells. This suggests that in
the absence of gp41 mediated cell death and fusion, HIV
transfer is the only consequence arising from the VS. Con-
sistently, the co-culture of primary CD4 T cells with BaL-
infected MOLT cells show a high level of p24 transfer to
target cells that are unaffected by C34, due to the low
impact of cell death and fusion (additional file 2). As
reported previously, most of the p24 captured by primaryRetrovirology 2009, 6:89 http://www.retrovirology.com/content/6/1/89
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cells at short times is internalized [18]. This observation
also applies to MT-4 cells, in which 63+/-5% of p24 cap-
tured from MOLT BaL cells at 2 hours are resistant to
trypsin, while at 24 hours 50+/-4% remain in trypsin
resistant compartments (data not shown, [15]) Of note, at
24 hours the amount of p24 accumulated in primary cells
by fusion-independent mechanisms was completely sen-
sitive to the anti-CD4 mAb Leu3a, suggesting that primary
CD4 T cells show a particular ability to capture HIV parti-
cles after engaging in VS formation. Taken together, these
data suggest that MT-4 cells (and by extension other CD4
cell lines) appear to be a suitable model to study HIV
transmission. Conversely, the high level of p24 trans-
ferred to primary CD4 T cells and their mostly quiescent
state are factors that hamper the rapid flow cytometric
quantification of infection events making these cells an
excellent model to explore the mechanisms involved in
early events of HIV transmission, namely HIV transfer.
On the mechanism of HIV transfer to primary CD4 T cells
An alternative approach to characterizing transport phe-
nomena at the VS is the evaluation of the transfer of mem-
brane lipids from MOLT infected cells to target cells.
Membrane transfer to single cells may be the consequence
of either hemifusion events between cells [22], or the
transfer of viral particles that may fuse with, or may be
endocytosed, by target cells. NL4-3 infected MOLT cells
induce high level of hemifusion and cell death in primary
cells. The addition of C34 blocks gp41-mediated cell
death but, as observed for p24 transfer, fail to abrogate
membrane capture by primary cells. Similarly, membrane
transfer to target cells is also observed for BaL infected
cells, and remarkably, is not inhibited by the addition of
C34. Of note, membrane transfer is tightly subjected to
Env binding to CD4 as it is completely inhibited with the
anti-CD4 antibody Leu3a (additional file 3). These data
suggest that under conditions in which fusion and hemi-
fusion events are completely blocked membranes are still
transferred across the VS. On the other hand, the transfer
of membranes from NL4-3 and BaL infected MOLT cells
to the MT-4 cell line is lower than that observed in pri-
mary cells. Notably, only the transfer of membranes from
NL4-3 infected MOLT cells to MT-4 cells is partially inhib-
ited by C34, suggesting that low levels of fusion-depend-
ent events are sufficient to induce an efficient infection of
cell lines during cell-to-cell HIV transmission (additional
file 3).
Although unstimulated primary CD4 T cells do not pro-
duce detectable amounts of HIV particles, they support
early events of HIV infection that can be measured by
quantifying the amount of newly synthesized HIV DNA
by real-time PCR [14,21]. The comparison of HIV infec-
tion with p24 and membrane transfer suggest that the lat-
ter process follows a CD4-dependent but fusion-
independent pathway, while proviral DNA synthesis is
completely prevented by both CD4 and gp41 blockade,
highlighting the differences between HIV transfer and
transmission (additional file 4).
Two non-exclusive mechanisms may explain the fusion-
independent transfer at the VS: first, a massive budding of
HIV particles that drag membrane components, followed
by a massive binding and endocytic capture by the unin-
fected target cell; and/or second, a trogocytic process
involving the transfer of membrane patches carrying HIV
budding machinery, a process that is probably linked to
the formation of bridged structures (Figure 1). Cumula-
tive evidence suggests that HIV transfer to primary cells
follows the first mechanism either by surfing along the
membrane bridges or as free particles released into the
synaptic space. Electron microscopy data, from an early
description [6] to a recent report by Chen et al. [20],
describe polarized Gag or Gag-GFP budding at the VS and
endosomal vesicles containing HIV particles in target
cells. Furthermore, biochemical data show that trans-
ferred HIV materials are directed towards trypsin resistant
compartments [18], and videomicroscopy shows the
vesicular transfer of large amounts of Gag, sporadically
involving entire synaptic buttons [20]. Although this lat-
ter observation may be consistent with trogocytic events,
we have described that trogocytosis occurs at the VS from
the target to the infected cells, but not in the direction of
viral transmission [14]. Of note, trogocytosis, which
requires the formation of bridged membrane structures, is
observed at the VS before co-receptor engagement, poten-
tially allowing for an open access of the HIV machinery to
the cytoplasm of the target cells (Figure 1). However, the
complete blockade of infection in the presence of fusion
inhibitors rules out the existence of gp41-independent
HIV transmission at the VS (additional file 4, [14]).
The differences observed between primary CD4 T cells
and a model cell line might be associated with the kinetics
of hemifusion/fusion events [23]. Delayed fusion at the
cell membrane may favor the duration of hemifusion,
increasing endocytosis and cell death events in primary
cells. In contrast, rapid fusion kinetics at the cell mem-
brane may favor transmission of HIV infection with lower
levels of endocytosis and gp41-mediated death. Assuming
that the endocytosis of HIV particles is the main mecha-
nism of HIV transfer in primary CD4 T cells and according
to the recent report by Miyauchi et al. [24] that describes
efficient HIV fusion with endosomal membranes in HeLa
cells, a hypothetical sequence of HIV transmission is illus-
trated in Figure 1. In the absence of functional co-receptor,
transfer but not infection occurs; target cells accumulate
high amounts of HIV particles in endosomal compart-
ments that fail to induce detectable proviral DNA synthe-
sis. In this case, HIV transfer may be defined as aRetrovirology 2009, 6:89 http://www.retrovirology.com/content/6/1/89
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Figure 1
Steps of HIV transmission. A portion of the VS (top left) has been enlarged to illustrate HIV transfer (A) and transmission
(B). Two mechanisms would be involved in the transfer of HIV materials from infected to target cells after the VS formation.
Both are dependent on Env binding to CD4 but independent of co-receptor engagement. First, a massive budding of viral parti-
cles from the infected cell (left) to the synaptic space (middle) and a further virion wrapping in the endosomal vesicles by the
target cells (right). Second, membrane patches from infected cells carrying HIV budding machinery could be transferred to
uninfected cells by trogocytosis through the formation of tethering tubes, potentially allowing for viral RNA to enter the cyto-
plasm of target cell (without exposure to the extracellular milieu). Furthermore, membrane tubes may help virions to surf
extracellularly towards the uninfected cell. For cell-to-cell transmission events (involving infection of target cells), viral particles
require both CD4 and the co-receptor, CXCR4 or CCR5, to fuse with the target cell. This process may occur at the plasma
membrane or in endosomal compartments, allowing for HIV RNA release into the cytoplasm and initiation of the infectious
cycle, after reverse transcription and nuclear import. In the absence of the co-receptor, transferred HIV particles accumulate
in the endosomal compartments.Retrovirology 2009, 6:89 http://www.retrovirology.com/content/6/1/89
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byproduct of HIV transmission, allowing transferred viri-
ons to be released and transmitted to third party cells [18],
or alternatively to be processed for antigen presentation.
Conversely, in co-receptor expressing target cells, trans-
ferred viruses may fuse with the endosomal membranes to
reach the cytoplasm and infect the target cells. Some
experimental evidence support this endosomal pathway
also in primary cells [25]. Irrespective of the entry path-
way preferred by HIV during cell-to-cell spread, fusion
inhibitors and neutralizing antibodies efficiently block
the infectious process [14].
Conclusion
In summary, evaluation of cell-to-cell HIV transmission is
highly dependent on the target cell type employed. Cell
lines are a good model to study HIV transmission as they
present an activated phenotype that enhances productive
infection; however, they show low ability to accumulate
HIV particles (HIV transfer) and may not completely
mimic primary cells. Freshly isolated primary CD4 T cells
are remarkably sensitive to HIV transfer but show low, if
any, capability to become productively infected. Given the
relevance of primary cells, this limitation can be overcome
by monitoring early events of the HIV life cycle such as the
synthesis of proviral DNA [14], or the access of HIV cores
to the cytoplasm using fluorescent techniques [26]. These
differences should be taken into account when analyzing
the inhibition of HIV transmission. In particular, the mis-
interpretation of HIV transfer as HIV transmission should
be avoided.
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